Histopathologic classification of ANCA-associated glomerulonephritis.
暂无分享,去创建一个
Irmgard Neumann | Kensuke Joh | R. Waldherr | C. Pusey | I. Neumann | F. Ferrario | D. Jayne | I. Bajema | J Charles Jennette | Ingeborg M Bajema | Jan A Bruijn | J. Jennette | L. Noël | E. C. Hagen | J. Bruijn | A. Berden | K. Joh | Franco Ferrario | Charles D Pusey | E Christiaan Hagen | Rüdiger Waldherr | Laure-Hélène Noël | Annelies E Berden | David R Jayne | E. Hagen
[1] J. Stone,et al. Correlation of Percentage of Normal Glomeruli with Renal Outcome in Wegener’s Granulomatosis , 2002, American Journal of Nephrology.
[2] R. Wolterbeek,et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. , 2006, Journal of the American Society of Nephrology : JASN.
[3] R. Falk,et al. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies , 2008, Current opinion in rheumatology.
[4] A. Soleiman,et al. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Journal of the American Society of Nephrology : JASN.
[6] S. Adler,et al. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] H. E. Hansen,et al. The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.
[8] Emile de Heer,et al. Immunopathological aspects of systemic vasculitis , 2009, Springer Seminars in Immunopathology.
[9] D. Abramowicz,et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. , 2007, Journal of the American Society of Nephrology : JASN.
[10] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] V. D’Agati,et al. Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[12] T. Dougan,et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. , 2004, Kidney international.
[13] L. Bostad,et al. Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] R. Falk,et al. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. , 1989, The American journal of pathology.
[15] V. D’Agati,et al. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[16] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[17] P. van Paassen,et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] J. Hermans,et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. , 1999, Kidney international.
[19] Agnes B Fogo,et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] H. Raspe,et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force , 2007, Annals of the rheumatic diseases.
[21] H. V. van Houwelingen,et al. An index for renal outcome in ANCA-associated glomerulonephritis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] J. Jennette. Rapidly progressive crescentic glomerulonephritis. , 2003, Kidney international.
[23] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] R. Frederick,et al. ANCA-associated glomerulonephritis : insights into etiology, pathogenesis, and prognosis , 2009 .
[25] David Roth,et al. A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .
[26] Y. Tomino,et al. Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan , 2008, Clinical and Experimental Nephrology.
[27] J. Ioannidis,et al. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] J. Hermans,et al. The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] S Senn,et al. Repeated measures in clinical trials: simple strategies for analysis using summary measures. , 2000, Statistics in medicine.
[30] R. Falk,et al. Small-vessel vasculitis. , 1997, The New England journal of medicine.
[31] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[32] H. V. van Houwelingen,et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. , 2002, Kidney international.
[33] H. V. van Houwelingen,et al. Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] D. Jayne,et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. , 1990, Kidney international.
[35] V. Tesar,et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. , 2003, The New England journal of medicine.
[36] V. D’Agati,et al. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. , 2008, Clinical journal of the American Society of Nephrology : CJASN.